Finerenone attenuates myocardial injury and enhances vascular repair via regulation of autophagy, apoptosis, and angiogenesis
Yebao Wang, Junyi Zhang, Feng Lv, Ting Zhang, Yafeng Zhou · 2026
Read Finerenone attenuates myocardial injury and enhances vascular repair via regulation of autophagy, apoptosis, and angiogenesis by Yebao Wang, Junyi Zhang, Feng Lv, Ting Zhang, Yafeng Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13507333.txt.
Description
Yebao Wang, Junyi Zhang, Feng Lv, Ting Zhang, and Yafeng Zhou test, in 2026 work, whether the drug finerenone directly shields heart and vessel cells after heart attack. Finerenone blocks a hormone receptor that drives scarring, and trials suggest benefit, but direct cell protection was unproven. Starved-oxygen cell models mimicked attack conditions, and mice received the drug daily for four weeks after induced infarction.
Treated heart and vessel lining cells survived better, cleared waste sacs faster instead of clogging, and died less by programmed death. Vessel cells also migrated and formed tubes more readily. In mice, pumping improved, scar size shrank, and inflammation and fibrosis eased. Growth signals for new vessels rose in heart tissue.
Catalog record
| CREATOR | Yebao Wang, Junyi Zhang, Feng Lv, Ting Zhang, Yafeng Zhou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41622 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |